The transcriptional regulator ZNF398 mediates pluripotency and epithelial character downstream of TGF-beta in human PSCs.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
12 05 2020
Historique:
received: 12 09 2019
accepted: 17 04 2020
entrez: 14 5 2020
pubmed: 14 5 2020
medline: 1 9 2020
Statut: epublish

Résumé

Human pluripotent stem cells (hPSCs) have the capacity to give rise to all differentiated cells of the adult. TGF-beta is used routinely for expansion of conventional hPSCs as flat epithelial colonies expressing the transcription factors POU5F1/OCT4, NANOG, SOX2. Here we report a global analysis of the transcriptional programme controlled by TGF-beta followed by an unbiased gain-of-function screening in multiple hPSC lines to identify factors mediating TGF-beta activity. We identify a quartet of transcriptional regulators promoting hPSC self-renewal including ZNF398, a human-specific mediator of pluripotency and epithelial character in hPSCs. Mechanistically, ZNF398 binds active promoters and enhancers together with SMAD3 and the histone acetyltransferase EP300, enabling transcription of TGF-beta targets. In the context of somatic cell reprogramming, inhibition of ZNF398 abolishes activation of pluripotency and epithelial genes and colony formation. Our findings have clear implications for the generation of bona fide hPSCs for regenerative medicine.

Identifiants

pubmed: 32398665
doi: 10.1038/s41467-020-16205-9
pii: 10.1038/s41467-020-16205-9
pmc: PMC7217929
doi:

Substances chimiques

Kruppel-Like Transcription Factors 0
RNA, Small Interfering 0
SMAD3 protein, human 0
Smad3 Protein 0
Transforming Growth Factor beta 0
ZNF398 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2364

Références

Thomson, J. A. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–1147 (1998).
doi: 10.1126/science.282.5391.1145
Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
pubmed: 18035408 doi: 10.1016/j.cell.2007.11.019 pmcid: 18035408
Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).
pubmed: 18029452 doi: 10.1126/science.1151526 pmcid: 18029452
Chen, G. et al. Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 8, 424–429 (2011).
pubmed: 21478862 pmcid: 3084903 doi: 10.1038/nmeth.1593
Ludwig, T. E. et al. Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 24, 185–187 (2006).
pubmed: 16388305 doi: 10.1038/nbt1177 pmcid: 16388305
Vallier, L. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 118, 4495–4509 (2005).
pubmed: 16179608 doi: 10.1242/jcs.02553 pmcid: 16179608
Beattie, G. M. et al. Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells 23, 489–495 (2005).
pubmed: 15790770 doi: 10.1634/stemcells.2004-0279 pmcid: 15790770
Chen, S., Choo, A., Chin, A. & Oh, S. K. W. TGF-β2 allows pluripotent human embryonic stem cell proliferation on E6/E7 immortalized mouse embryonic fibroblasts. J. Biotechnol. 122, 341–361 (2006).
pubmed: 16494961 doi: 10.1016/j.jbiotec.2005.11.022 pmcid: 16494961
Eiselleova, L. et al. Comparative study of mouse and human feeder cells for human embryonic stem cells. Int. J. Dev. Biol. 52, 353–363 (2008).
pubmed: 18415935 doi: 10.1387/ijdb.082590le pmcid: 18415935
Vallier, L. et al. Activin/Nodal signalling maintains pluripotency by controlling Nanog expression. Development 136, 1339–1349 (2009).
pubmed: 19279133 pmcid: 2687465 doi: 10.1242/dev.033951
Xu, R.-H. et al. NANOG is a direct target of TGFβ/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 3, 196–206 (2008).
pubmed: 18682241 pmcid: 2758041 doi: 10.1016/j.stem.2008.07.001
Ross, S. & Hill, C. S. How the Smads regulate transcription. Int. J. Biochem. Cell Biol. 40, 383–408 (2008).
pubmed: 18061509 doi: 10.1016/j.biocel.2007.09.006 pmcid: 18061509
Massagué, J., Seoane, J. & Wotton, D. Smad transcription factors. Genes Dev. 19, 2783–2810 (2005).
pubmed: 16322555 doi: 10.1101/gad.1350705 pmcid: 16322555
Lucarelli, P. et al. Resolving the combinatorial complexity of smad protein complex formation and its link to gene expression. Cell Syst. 6, 75–89.e11 (2018).
pubmed: 29248373 doi: 10.1016/j.cels.2017.11.010 pmcid: 29248373
Mullen, A. C. et al. Master transcription factors determine cell-type-specific responses to TGF-β signaling. Cell 147, 565–576 (2011).
pubmed: 22036565 pmcid: 3212730 doi: 10.1016/j.cell.2011.08.050
Chambers, I. et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643–655 (2003).
pubmed: 12787505 doi: 10.1016/S0092-8674(03)00392-1 pmcid: 12787505
Masui, S. et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 9, 625–635 (2007).
pubmed: 17515932 doi: 10.1038/ncb1589 pmcid: 17515932
Nichols, J. et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379–391 (1998).
pubmed: 9814708 doi: 10.1016/S0092-8674(00)81769-9 pmcid: 9814708
Wang, Z., Oron, E., Nelson, B., Razis, S. & Ivanova, N. Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells. Cell Stem Cell 10, 440–454 (2012).
doi: 10.1016/j.stem.2012.02.016
Dunn, S. J., Martello, G., Yordanov, B., Emmott, S. & Smith, A. G. Defining an essential transcription factor program for naïve pluripotency. Science 344, 1156–1160 (2014).
pubmed: 24904165 pmcid: 4257066 doi: 10.1126/science.1248882
Takashima, Y. et al. Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell 158, 1254–1269 (2014).
pubmed: 25215486 pmcid: 4162745 doi: 10.1016/j.cell.2014.08.029
Guo, G. et al. Naïve pluripotent stem cells derived directly from isolated cells of the human inner cell mass. Stem Cell Rep. 6, 437–446 (2016).
doi: 10.1016/j.stemcr.2016.02.005
Giulitti, S. et al. Direct generation of human naïve induced pluripotent stem cells from somatic cells in microfluidics. Nat. Cell Biol. 21, 275–286 (2019).
pubmed: 30598530 doi: 10.1038/s41556-018-0254-5 pmcid: 30598530
Weinberger, L., Ayyash, M., Novershtern, N. & Hanna, J. H. Dynamic stem cell states: Naive to primed pluripotency in rodents and humans. Nat. Rev. Mol. Cell Biol. 17, 155–169 (2016).
pubmed: 26860365 doi: 10.1038/nrm.2015.28 pmcid: 26860365
Eastham, A. M. et al. Epithelial–mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res. 67, 11254–11262 (2007).
pubmed: 18056451 doi: 10.1158/0008-5472.CAN-07-2253 pmcid: 18056451
Martello, G. et al. Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal. Stem Cell 11, 491–504 (2012).
Martello, G., Bertone, P. & Smith, A. Identification of the missing pluripotency mediator downstream of leukaemia inhibitory factor. EMBO J. 32, 2561–2574 (2013).
pubmed: 23942233 pmcid: 3791366 doi: 10.1038/emboj.2013.177
Senft, A. D. et al. Combinatorial Smad2/3 activities downstream of nodal signaling maintain embryonic/extra-embryonic cell identities during lineage priming. Cell Rep. 24, 1977–1985.e7 (2018).
pubmed: 30134160 pmcid: 6113931 doi: 10.1016/j.celrep.2018.07.077
Zhang, X. et al. FOXO1 is an essential regulator of pluripotency in human embryonic stem cells. Nat. Cell Biol. 13, 1092–1101 (2011).
pubmed: 21804543 pmcid: 4053529 doi: 10.1038/ncb2293
Chia, N.-Y. et al. A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature 468, 316–320 (2010).
pubmed: 20953172 doi: 10.1038/nature09531 pmcid: 20953172
Wang, Z. et al. A non-canonical BCOR-PRC1.1 complex represses differentiation programs in human ESCs. Cell Stem Cell 22, 235–251.e9 (2018).
pubmed: 29337181 pmcid: 5797497 doi: 10.1016/j.stem.2017.12.002
Zhang, J. et al. LIN28 regulates stem cell metabolism and conversion to primed pluripotency. Cell Stem Cell 19, 66–80 (2016).
pubmed: 27320042 doi: 10.1016/j.stem.2016.05.009 pmcid: 27320042
Hernandez, C. et al. Dppa2/4 facilitate epigenetic remodeling during reprogramming to pluripotency. Cell Stem Cell 23, 396–411.e8 (2018).
pubmed: 30146411 pmcid: 6128737 doi: 10.1016/j.stem.2018.08.001
Kooistra, S. M., Thummer, R. P. & Eggen, B. J. L. Characterization of human UTF1, a chromatin-associated protein with repressor activity expressed in pluripotent cells. Stem Cell Res. 2, 211–218 (2009).
pubmed: 19393592 doi: 10.1016/j.scr.2009.02.001 pmcid: 19393592
Brons, I. G. M. et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448, 191–195 (2007).
pubmed: 17597762 pmcid: 17597762 doi: 10.1038/nature05950
Tesar, P. J. et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448, 196–199 (2007).
pubmed: 17597760 pmcid: 17597760 doi: 10.1038/nature05972
Nichols, J. & Smith, A. Naïve and primed pluripotent states. Cell Stem Cell 4, 487–492 (2009).
pubmed: 19497275 pmcid: 19497275 doi: 10.1016/j.stem.2009.05.015
Yang, J. et al. Stat3 activation is limiting for reprogramming to ground state pluripotency. Cell Stem Cell 7, 319–328 (2010).
pubmed: 20804969 pmcid: 3459098 doi: 10.1016/j.stem.2010.06.022
Cliff, T. S. et al. MYC controls human pluripotent stem cell fate decisions through regulation of metabolic flux. Stem Cell 21, 502–516.e9 (2017).
Yamane, M., Ohtsuka, S., Matsuura, K., Nakamura, A. & Niwa, H. Overlapping functions of Krüppel-like factor family members: targeting multiple transcription factors to maintain the naïve pluripotency of mouse embryonic stem cells. Development 145, dev162404 (2018).
pubmed: 29739838 doi: 10.1242/dev.162404 pmcid: 29739838
Muñoz-Sanjuán, I. & Brivanlou, A. H. Neural induction, the default model and embryonic stem cells. Nat. Rev. Neurosci. 3, 271–280 (2002).
pubmed: 11967557 doi: 10.1038/nrn786 pmcid: 11967557
Vallier, L., Reynolds, D. & Pedersen, R. A. Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev. Biol. 275, 403–421 (2004).
pubmed: 15501227 doi: 10.1016/j.ydbio.2004.08.031 pmcid: 15501227
Chambers, S. M. et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27, 275–280 (2009).
pubmed: 19252484 pmcid: 2756723 doi: 10.1038/nbt.1529
Conroy, A. T. et al. A novel zinc finger transcription factor with two isoforms that are differentially repressed by estrogen receptor-alpha. J. Biol. Chem. 277, 9326–9334 (2002).
pubmed: 11779858 doi: 10.1074/jbc.M107702200 pmcid: 11779858
Sánchez-Castillo, M. et al. CODEX: a next-generation sequencing experiment database for the haematopoietic and embryonic stem cell communities. Nucleic Acids Res. 43, D1117–D1123 (2015).
pubmed: 25270877 doi: 10.1093/nar/gku895 pmcid: 25270877
Warzecha, C. C. et al. An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. EMBO J. 29, 3286–3300 (2010).
pubmed: 20711167 pmcid: 2957203 doi: 10.1038/emboj.2010.195
Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618–630 (2010).
pubmed: 20888316 pmcid: 3656821 doi: 10.1016/j.stem.2010.08.012
Gagliano, O. et al. Microfluidic reprogramming to pluripotency of human somatic cells. Nat. Protoc. 14, 722–737 (2019).
pubmed: 30809022 doi: 10.1038/s41596-018-0108-4 pmcid: 30809022
Yilmaz, A., Peretz, M., Aharony, A., Sagi, I. & Benvenisty, N. Defining essential genes for human pluripotent stem cells by CRISPR-Cas9 screening in haploid cells. Nat. Cell Biol. 20, 610–619 (2018).
pubmed: 29662178 doi: 10.1038/s41556-018-0088-1 pmcid: 29662178
Hackett, J. A. et al. Tracing the transitions from pluripotency to germ cell fate with CRISPR screening. Nat. Commun. 9, 4292 (2018).
pubmed: 30327475 pmcid: 6191455 doi: 10.1038/s41467-018-06230-0
Lyden, D. et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401, 670–677 (1999).
pubmed: 10537105 doi: 10.1038/44334 pmcid: 10537105
Ying, Q.-L., Nichols, J., Chambers, I. & Smith, A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281–292 (2003).
pubmed: 14636556 pmcid: 14636556 doi: 10.1016/S0092-8674(03)00847-X
Liang, Y.-Y., Brunicardi, F. C. & Lin, X. Smad3 mediates immediate early induction of Id1 by TGF-beta. Cell Res. 19, 140–148 (2009).
pubmed: 19079362 doi: 10.1038/cr.2008.321 pmcid: 19079362
Imbeault, M., Helleboid, P.-Y. & Trono, D. KRAB zinc-finger proteins contribute to the evolution of gene regulatory networks. Nature 543, 550–554 (2017).
pubmed: 28273063 doi: 10.1038/nature21683 pmcid: 28273063
Stabach, P. R., Thiyagarajan, M. M. & Weigel, R. J. Expression of ZER6 in ERα-positive breast cancer. J. Surg. Res. 126, 86–91 (2005).
pubmed: 15916980 doi: 10.1016/j.jss.2005.02.006 pmcid: 15916980
Huang, C. et al. Zinc-finger protein p52-ZER6 accelerates colorectal cancer cell proliferation and tumour progression through promoting p53 ubiquitination. EBioMedicine 48, 248–263 (2019).
pubmed: 31521611 pmcid: 6838388 doi: 10.1016/j.ebiom.2019.08.070
Reubinoff, B. E., Pera, M. F., Fong, C.-Y., Trounson, A. & Bongso, A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18, 399–404 (2000).
pubmed: 10748519 doi: 10.1038/74447 pmcid: 10748519
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
doi: 10.1038/nmeth.2019
Montagner, M. et al. Crosstalk with lung epithelial cells regulates Sfrp2 -mediated latency in breast cancer dissemination. Nat. Cell Biol. 22, 289–296 (2020).
pubmed: 32094692 doi: 10.1038/s41556-020-0474-3 pmcid: 32094692
Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinforma. Oxf. Engl. 26, 139–140 (2010).
doi: 10.1093/bioinformatics/btp616
Anders, S., Pyl, P. T. & Huber, W. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169 (2015).
pubmed: 25260700 pmcid: 25260700 doi: 10.1093/bioinformatics/btu638
Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).
pubmed: 20979621 pmcid: 3218662 doi: 10.1186/gb-2010-11-10-r106
Dennis, G. et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 4, R60 (2003).
pmcid: 193660 doi: 10.1186/gb-2003-4-9-r60 pubmed: 193660
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
pubmed: 25605792 pmcid: 4402510 doi: 10.1093/nar/gkv007
Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
pubmed: 19261174 pmcid: 2690996 doi: 10.1186/gb-2009-10-3-r25
Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
pubmed: 18798982 pmcid: 2592715 doi: 10.1186/gb-2008-9-9-r137
Kim, J., Cantor, A. B., Orkin, S. H. & Wang, J. Use of in vivo biotinylation to study protein–protein and protein–DNA interactions in mouse embryonic stem cells. Nat. Protoc. 4, 506–517 (2009).
pubmed: 19325547 doi: 10.1038/nprot.2009.23 pmcid: 19325547
Krepelova, A., Neri, F., Maldotti, M., Rapelli, S. & Oliviero, S. Myc and Max genome-wide binding sites analysis links the Myc regulatory network with the polycomb and the core pluripotency networks in mouse embryonic stem cells. PLoS ONE 9, 1–12 (2014).
doi: 10.1371/journal.pone.0088933
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinforma. Oxf. Engl. 26, 841–842 (2010).
doi: 10.1093/bioinformatics/btq033
Bailey, T. L. et al. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 37, W202–W208 (2009).
pubmed: 19458158 pmcid: 2703892 doi: 10.1093/nar/gkp335
Ramírez, F., Dündar, F., Diehl, S., Grüning, B. A. & Manke, T. deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res. 42, W187–W191 (2014).
pubmed: 24799436 pmcid: 4086134 doi: 10.1093/nar/gku365
Rada-Iglesias, A. et al. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470, 279–283 (2011).
pubmed: 21160473 doi: 10.1038/nature09692 pmcid: 21160473

Auteurs

Irene Zorzan (I)

Department of Molecular Medicine, Medical School, University of Padua, 35121, Padua, Italy.

Marco Pellegrini (M)

Department of Molecular Medicine, Medical School, University of Padua, 35121, Padua, Italy.
UCL Great Ormond Street Institute of Child Health, Developmental Biology and Cancer, Stem Cells and Regenerative Medicine, 30 Guilford Street, WC1N 1EH, London, UK.

Mattia Arboit (M)

Department of Molecular Medicine, Medical School, University of Padua, 35121, Padua, Italy.

Danny Incarnato (D)

Department of Life Sciences and Systems Biology and Molecular Biotechnology Center (MCB), University of Turin, 10126, Turin, Italy.
Italian Institute for Genomic Medicine (IIGM), 10060, Candiolo (TO), Italy.
Department of Molecular Genetics, Groningen Biomolecular Sciences and Biotechnology Institute (GBB), University of Groningen, Nijenborgh 7, 9747 AG, Groningen, the Netherlands.

Mara Maldotti (M)

Department of Life Sciences and Systems Biology and Molecular Biotechnology Center (MCB), University of Turin, 10126, Turin, Italy.
Italian Institute for Genomic Medicine (IIGM), 10060, Candiolo (TO), Italy.

Mattia Forcato (M)

Department of Life Sciences, University of Modena and Reggio Emilia, 41125, Modena, Italy.

Guidantonio Malagoli Tagliazucchi (GM)

Department of Life Sciences, University of Modena and Reggio Emilia, 41125, Modena, Italy.
UCL Genetics Institute, Department of Genetics, Evolution and Environment, University College London, Darwin Building, WC1E 6BT, London, UK.

Elena Carbognin (E)

Department of Molecular Medicine, Medical School, University of Padua, 35121, Padua, Italy.

Marco Montagner (M)

Department of Molecular Medicine, Medical School, University of Padua, 35121, Padua, Italy.

Salvatore Oliviero (S)

Department of Life Sciences and Systems Biology and Molecular Biotechnology Center (MCB), University of Turin, 10126, Turin, Italy. salvatore.oliviero@unito.it.
Italian Institute for Genomic Medicine (IIGM), 10060, Candiolo (TO), Italy. salvatore.oliviero@unito.it.

Graziano Martello (G)

Department of Molecular Medicine, Medical School, University of Padua, 35121, Padua, Italy. graziano.martello@unipd.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH